Molsidomine

Therapeutic Area

Cardiovascular system

Status

Commercial

EU DMF readiness

CEP

CAS No.

25717-80-0

Reference Product

Drug description:

Molsidomine is a long-acting vasodilator used to treat angina pectoris, including in association with left heart failure and acute myocardial infarction. Molsidomine is an orally active, long-acting vasodilator, which belongs to the class of medications known as syndnones.
It is formulated as tablets for oral route of administration.

Mechanism of action:

Molsidomine, a cardiovascular drug, acts in a similar fashion to organic nitrates. The SIN-1A metabolite of molsidomine has a pharmacologically active group of nitric oxide, which increases levels of cyclic GMP, and decreases intracellular calcium ions in smooth muscle cells. This leads to relaxation of smooth muscle in the blood vessels, and inhibits platelet aggregation.